REG - CVS Group plc - Total Voting Rights

CVSAnnouncement

31/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250331:nRSe6859Ca&default-theme=true

RNS Number : 6859C  CVS Group plc  31 March 2025

31 March 2025

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, announces that, as of 31 March 2025, the Company's total issued
share capital consists of 71,740,184 Ordinary Shares of 0.2p each with each
one carrying one voting right. The Company holds no Ordinary Shares in
treasury and the total number of voting rights is therefore 71,740,184.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

Contacts:

CVS Group
plc                                                                                                                    via
Camarco

Richard Fairman, Chief Executive Officer

Robin Alfonso, Chief Financial Officer

Paul Higgs, Chief Veterinary Officer

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
                              +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

Berenberg (Joint
Broker)                                                                                              +44
(0)20 3207 7800

Toby Flaux / Michael Burke / James Thompson / Milo Bonser

 

Camarco (Financial PR)
 

Ginny Pulbrook
 
                 +44 (0)20 3757 4980

Tilly Butcher

Letaba Rimell
 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK, and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.460 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices) and an online retail business ("Animed Direct").

 

 The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons
and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKFBBCBKKDNB